Heart Failure Clinical Trial
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
Summary
The REVERSE-HF study is a randomized controlled trial to evaluate clinical outcomes of adjustable ultrafiltration with the Aquadex System as compared to adjustable IV loop diuretics in patients with worsening heart failure (HF) and fluid overload.
Eligibility Criteria
Inclusion Criteria:
18 years or older
Man, or non-pregnant woman
Admitted to the hospital with a primary diagnosis of acute decompensated heart failure
On regularly prescribed oral loop diuretics prior to admission
Fluid overload manifested by at least three clinical indications (e.g., edema, an excess of at least 10 pounds of fluid, etc.)
Provide written informed consent
Exclusion Criteria:
New diagnosis of heart failure
Acute coronary syndromes
Creatinine ≥ 3.0 mg/dl or planned renal replacement therapies at the time of enrollment
Contraindications to systemic anticoagulation
Severe concomitant disease expected to prolong hospitalization or cause death in less than 90 days
Sepsis or ongoing systemic infection
Active myocarditis
Constrictive pericarditis or restrictive cardiomyopathy
Severe aortic stenosis
Any condition in the opinion of the investigator that would prevent the patient from follow-up/survival
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 12 Locations for this study
Tucson Arizona, 85721, United States More Info
Principal Investigator
San Diego California, 92123, United States More Info
Principal Investigator
San Francisco California, 94143, United States More Info
Principal Investigator
Clearwater Florida, 33756, United States More Info
Principal Investigator
Tampa Florida, 33614, United States More Info
Principal Investigator
Lexington Kentucky, 40536, United States More Info
Principal Investigator
New York New York, 10029, United States More Info
Principal Investigator
New York New York, 10075, United States More Info
Principal Investigator
Columbus Ohio, 43215, United States More Info
Principal Investigator
Abington Pennsylvania, 19001, United States More Info
Principal Investigator
Jackson Tennessee, 38301, United States More Info
Principal Investigator
Dallas Texas, 75207, United States More Info
Principal Investigator
How clear is this clinincal trial information?